These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

551 related items for PubMed ID: 17605740

  • 1. Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.
    West P, Schmiedeskamp M, Neeley H, Oberholzer J, Benedetti E, Kaplan B.
    Transpl Infect Dis; 2008 Apr; 10(2):129-32. PubMed ID: 17605740
    [Abstract] [Full Text] [Related]

  • 2. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ, Zaas AK, Hanson KE, Palmer SM.
    J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.
    Myhre HA, Haug Dorenberg D, Kristiansen KI, Rollag H, Leivestad T, Asberg A, Hartmann A.
    Transplantation; 2011 Jul 27; 92(2):217-23. PubMed ID: 21685829
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
    Oshima K, Kanda Y, Kako S, Asano-Mori Y, Watanabe T, Motokura T, Chiba S, Shiraki K, Kurokawa M.
    J Med Virol; 2008 Oct 27; 80(10):1769-75. PubMed ID: 18712833
    [Abstract] [Full Text] [Related]

  • 7. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
    Nogueira E, Ozaki KS, Tomiyama H, Granato CF, Camara NO, Pacheco-Silva A.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):2031-7. PubMed ID: 17161359
    [Abstract] [Full Text] [Related]

  • 8. Viral monitoring and successful treatment of a ganciclovir-resistant cytomegalovirus infection in a heart transplant recipient.
    García-Martínez J, Folgueira L, Delgado R, Hernando S, Prieto C, Aguado JM, Otero JR.
    Transpl Infect Dis; 2008 Apr 20; 10(2):123-8. PubMed ID: 17605746
    [Abstract] [Full Text] [Related]

  • 9. Case study: rapid emergence of a cytomegalovirus UL97 mutant in a heart-transplant recipient on pre-emptive ganciclovir therapy.
    Gilbert C, LeBlanc MH, Boivin G.
    Herpes; 2001 Nov 20; 8(3):80-2. PubMed ID: 11867025
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients.
    Mylonakis E, Kallas WM, Fishman JA.
    Clin Infect Dis; 2002 May 15; 34(10):1337-41. PubMed ID: 11981729
    [Abstract] [Full Text] [Related]

  • 12. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.
    Scott GM, Isaacs MA, Zeng F, Kesson AM, Rawlinson WD.
    J Med Virol; 2004 Sep 15; 74(1):85-93. PubMed ID: 15258973
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Letermovir successfully used for secondary prophylaxis in a heart transplant recipient with ganciclovir-resistant cytomegalovirus syndrome (UL97 mutation).
    Chong PP, Teiber D, Prokesch BC, Arasaratnam RJ, Peltz M, Drazner MH, Garg S.
    Transpl Infect Dis; 2018 Oct 15; 20(5):e12965. PubMed ID: 29989279
    [Abstract] [Full Text] [Related]

  • 15. Mass spectrometry-based comparative sequencing to detect ganciclovir resistance in the UL97 gene of human cytomegalovirus.
    Posthuma CC, van der Beek MT, van der Blij-de Brouwer CS, van der Heiden PL, Marijt EW, Spaan WJ, Claas EC, Nederstigt C, Vossen AC, Snijder EJ, Kroes AC.
    J Clin Virol; 2011 May 15; 51(1):25-30. PubMed ID: 21388868
    [Abstract] [Full Text] [Related]

  • 16. Aciclovir selects for ganciclovir-cross-resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein.
    Michel D, Höhn S, Haller T, Jun D, Mertens T.
    J Med Virol; 2001 Sep 15; 65(1):70-6. PubMed ID: 11505446
    [Abstract] [Full Text] [Related]

  • 17. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.
    Limaye AP, Corey L, Koelle DM, Davis CL, Boeckh M.
    Lancet; 2000 Aug 19; 356(9230):645-9. PubMed ID: 10968438
    [Abstract] [Full Text] [Related]

  • 18. [Strains of ganciclovir-resistant cytomegalovirus].
    Calicó I, García E, Cortés A, Gavaldá J, Roman A, Valle I.
    Enferm Infecc Microbiol Clin; 1999 Aug 19; 17(7):330-4. PubMed ID: 10535184
    [Abstract] [Full Text] [Related]

  • 19. Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child.
    Prix L, Hamprecht K, Holzhüter B, Handgretinger R, Klingebiel T, Jahn G.
    J Infect Dis; 1999 Aug 19; 180(2):491-5. PubMed ID: 10395867
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.